Skip Over Navigation Links
National Institutes of Health
:

Clinical Trials

HIV/AIDS

Featured Studies

Featured studies include only those currently recruiting participants. They are listed according to the date they were added to the ClinicalTrials.gov registry, with the most recent studies appearing first.

  • Providing Voluntary HIV Counseling and Testing Plus Linkage to Care in Uganda.
    Interventional study. This study will compare the effectiveness of brief versus detailed HIV counseling sessions, paired with referrals to either HIV-specific medical care or usual care, in reducing HIV risk behavior and in increasing treatment adherence in Uganda. Ages 18 and over. Location in Kampala, Uganda.
  • Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China.
    Interventional study. This study will evaluate the effectiveness of a physician training program, the Ai Shi Zi program, in improving HIV/sexually transmitted infection diagnosis, treatment, and management by Chinese physicians and in reducing the number of subsequent infections in their patients. Ages 18-45. Location in Hefei, China.
  • Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women.
    Interventional study. This study will evaluate the effectiveness of CenteringPregnancy Plus, a group prenatal care treatment program with an HIV/sexually transmitted disease prevention component, in reducing health risk behaviors in pregnant teenagers seeking services at Community Health Centers in the New York metropolitan area. Ages 14-21. Locations in Cheshire, CT; New Haven, CT; New York, NY.
  • Effects of HIV and Hepatitis C Virus on the Brain.
    Evaluation study. This study will determine the effects that HIV and hepatitis C virus have on thinking abilities and whether the viruses affect brain chemistry. Ages 18-65. Location in New York, NY.
  • STD Risk Reduction for Heterosexual Methamphetamine Users.
    Interventional study. This study will evaluate the effectiveness of a sexual risk reduction intervention in reducing sexual risk behavior in HIV uninfected, heterosexual people who use methamphetamine. Ages 18 and over. Location in San Diego, CA.

Search ClinicalTrials.gov for other NIH studies on HIV/AIDS.